CLINICAL RESPONSE TO A SECOND UTERINE CURETTAGE IN PATIENTS WITH LOW-RISK GESTATIONAL TROPHOBLASTIC DISEASE: A PILOT STUDY

被引：0
作者：
Yarandi, F. [1 ]
Ali, E. Shir [1 ]
机构：
[1] Teharn Univ Med Sci, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.1187
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1146
引用
收藏
页码：A595 / A595
页数：1
相关论文
共 50 条
  • [21] A PHASE II STUDY TO DETERMINE THE RESPONSE TO SECOND CURETTAGE AS INITIAL MANAGEMENT FOR PERSISTENT "LOW-RISK" NON-METASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA: A GYNECOLOGIC ONCOLOGY GROUP STUDY.
    Osborne, R.
    Filiaci, V. L.
    Mannel, R. S.
    Davidson, S. A.
    Hoffman, J. S.
    Spirtos, N. M.
    Chan, J. K.
    Schink, J. S.
    Tidy, J.
    Miller, D. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1096 - 1097
  • [22] Evaluation of curative effect of re-curettage on the number of chemotherapy courses in low risk persistent gestational trophoblastic disease; a pilot randomized clinical trial study
    Ayatollahi, H.
    Afsari, E.
    Yekta, Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 504 - 504
  • [23] EVALUATION OF CURATIVE EFFECT OF RE-CURETTAGE ON THE NUMBER OF CHEMOTHERAPY COURSES IN LOW RISK PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE; A PILOT RANDOMIZED CLINICAL TRIAL STUDY
    Ayatollahi, H.
    Yekta, Z.
    Afsari, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1606 - 1606
  • [24] Significance of Chest Computed Tomography in the Clinical Outcome of Patients with Low-Risk Gestational Trophoblastic Neoplasia
    De Ramos, Maria Febi B.
    Soriano-Estrella, Agnes L.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2018, 63 (5-6) : 223 - 227
  • [25] Optimal management of low-risk gestational trophoblastic neoplasia
    Goldstein, Donald P.
    Berkowitz, Ross S.
    Horowitz, Neil S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1293 - 1304
  • [26] Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
    Braga, Antonio
    Elias, Kevin M.
    Horowitz, Neil S.
    Berkowitz, Ross S.
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2021, 43 (07): : 503 - 506
  • [27] Single-agent methotrexate for low-risk gestational trophoblastic disease.
    Lippmann, Q. K.
    Hanna, R. K.
    Soper, J. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] May platelet count be a predictor of low-risk persistent gestational trophoblastic disease?
    Verit, Fatma Ferda
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (04) : 695 - 699
  • [29] May platelet count be a predictor of low-risk persistent gestational trophoblastic disease?
    Fatma Ferda Verit
    Archives of Gynecology and Obstetrics, 2011, 283 : 695 - 699
  • [30] Hysterectomy in case of low-risk gestational trophoblastic neoplasia
    Massardier, J.
    Mathe, M.
    Bolze, P. -A.
    Hajri, T.
    Devouassoux-Shisheboran, M.
    Schott, A. -M.
    Lotz, J. -P.
    You, B.
    Golfier, F.
    ONCOLOGIE, 2014, 16 (06) : 285 - 290
12345